Population and Public Health
HIMSS23
HIMSS and a number of countries have created a to-do list for improving access and health equity, says Tom Leary, SVP and head of government relations at HIMSS.
HIMSS23
Dr. Daniel Turner-Lloveras, cofounder and president of SaludConTech, discusses digital health's role in addressing healthcare disparities and improving access to healthcare services for communities of color.
HIMSS23
EndeavorRx gives children with ADHD another treatment option to improve attention, notes Scott Kollins, chief medical officer at Akili Interactive.
Elena Sini, board of directors chair at HIMSS, alongside Hal Wolf, president and CEO of HIMSS, announce HIMSS European conference will be held in Rome, Italy in May of next year and provide teasers regarding the venue in the Eternal City.
HIMSS23
Dan Soule, VP of Technology Operations at Health Catalyst, discusses the great strides made in health equity over the last 10 years as well as how AI is finally moving forward with real-world uses.
HIMSS23
Hal Wolf, HIMSS president and CEO, discusses the organization's announcement of establishing its international headquarters in Rotterdam and how it impacts HIMSS' chapters and partnerships working to advance digital transformation globally.
HIMSS23
Lightbeam Health Solutions president Jerry Shultz and CareSignal CEO Blake Marggraff describe recent Lightbeam moves to provide its customers with solutions that improve quality of care while reducing cost of care.
HIMSS23
A.C. Locklear, federal relations director for the National Indian Health Board, is looking to other groups with similar issues for new and innovative solutions to tribal health issues.
HIMSS23
Dr. Sameer Vohra, director of Illinois Department of Health, explains how the data IDPH has on hand can be used to better understand its communities and improve residents' lives.
HIMSS23
Tim O'Connell, CEO and founder of Emtelligent, talks about Emtelligent's NLP software, which is specially designed to understand medical English, and how it can assist drug companies with finding clinical trial cohorts from patient records.